Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3597075)

Published in Acta Neurochir Suppl on January 01, 2013

Authors

J Javier Provencio1

Author Affiliations

1: Department of Neurology, Cleveland Clinic, Cleveland, OH 44195, USA. provenj@ccf.org

Articles citing this

Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome? Stroke (2013) 2.07

The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2013) 1.18

The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery (2013) 0.84

Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: possible involvement of inflammatory signaling. J Neuroinflammation (2013) 0.82

Immune cells subpopulations in cerebrospinal fluid and peripheral blood of patients with Aneurysmal Subarachnoid Hemorrhage. Springerplus (2015) 0.80

Neutrophil depletion after subarachnoid hemorrhage improves memory via NMDA receptors. Brain Behav Immun (2016) 0.78

Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial. J Cereb Blood Flow Metab (2015) 0.76

Massive Cerebrospinal Fluid Replacement Reduces Delayed Cerebral Vasospasm After Embolization of Aneurysmal Subarachnoid Hemorrhage. Med Sci Monit (2016) 0.75

Dehydroepiandrosterone sulphate: diabolical hormone or epiphenomenon in aneurysmal subarachnoid hemorrhage? Crit Care (2015) 0.75

Rescue therapy for refractory vasospasm after subarachnoid hemorrhage. Curr Neurol Neurosci Rep (2015) 0.75

Effect of Age on Transcranial Doppler Velocities in Patients with Aneurysmal Subarachnoid Hemorrhage. Eur Neurol (2016) 0.75

Monitoring the Neuroinflammatory Response Following Acute Brain Injury. Front Neurol (2017) 0.75

Hematologic counts as predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Crit Care (2016) 0.75

Articles cited by this

DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73

Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (2002) 3.13

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke (2008) 2.90

The immune system. First of two parts. N Engl J Med (2000) 2.05

Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol (2010) 1.69

Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2011) 1.58

Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci (2007) 1.49

Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int (2004) 1.48

Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci U S A (2001) 1.34

THE PATHOGENESIS OF CEREBRAL INFARCTION FOLLOWING THE RUPTURE OF CEREBRAL BERRY ANEURYSMS. Brain (1964) 1.34

Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg (1978) 1.30

Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus (2006) 1.19

Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology. Neurocrit Care (2004) 1.18

Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2006) 1.14

CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit Care (2010) 1.11

Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2005) 1.10

Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg (1998) 1.10

Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke (2001) 1.10

A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care (2006) 1.09

Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke (2004) 1.07

Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke (2007) 1.07

Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl) (2009) 1.07

Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg (1998) 1.06

Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg (2003) 1.05

Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci Lett (2000) 1.04

Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg (1998) 1.04

A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg (1994) 1.03

Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res (1998) 1.03

Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery (2002) 1.02

Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett (2004) 0.98

Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus (2006) 0.98

Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res (2006) 0.96

Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg (2004) 0.94

Nitric oxide and subarachnoid hemorrhage: elevated level in cerebrospinal fluid and their implications. Neurosurgery (2001) 0.92

Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke (2005) 0.92

Mice lacking in gp91 phox subunit of NAD(P)H oxidase showed glomus cell [Ca(2+)](i) and respiratory responses to hypoxia. Brain Res (2000) 0.91

Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage. J Neuroimmunol (2010) 0.91

Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients. Neurol Med Chir (Tokyo) (1997) 0.90

Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res (1995) 0.90

The influence of subarachnoid hemorrhage on neurons: an animal model. Ann Clin Lab Sci (2005) 0.89

Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm. Acta Neuropathol (1991) 0.88

Hydrogen peroxide induces contraction and raises [Ca2+]i in canine cerebral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.88

Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab (2002) 0.88

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats. J Neurosurg (2002) 0.87

The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. J Neurosurg Sci (1987) 0.86

Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg (2003) 0.86

The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery (1991) 0.85

Systemic administration of LPS worsens delayed deterioration associated with vasospasm after subarachnoid hemorrhage through a myeloid cell-dependent mechanism. Neurocrit Care (2012) 0.84

Is the vasospasm following subarachnoidal hemorrhage an immunoreactive disease? Experientia (1981) 0.83

The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers. Isr Med Assoc J (2002) 0.83

The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain (1974) 0.82

Nitric oxide related pathophysiological changes following subarachnoid haemorrhage. Acta Neurochir Suppl (2011) 0.82

Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery (2004) 0.82

Alleviation of brain edema by L-arginine following experimental subarachnoid hemorrhage in a rat model. Clin Hemorheol Microcirc (2003) 0.81

Expression of interleukin-1 beta in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neurosci Lett (2001) 0.81

Is vasospasm related to proliferative arteriopathy? J Neurosurg (1992) 0.80

Is vascular angiopathy following intracranial aneurysm rupture immunologically mediated? Acta Neurochir (Wien) (1992) 0.79

Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats. Acta Neurochir (Wien) (1994) 0.79

No apparent role for neutrophils and neutrophil-derived myeloperoxidase in experimental subarachnoid haemorrhage and vasospasm: a preliminary study. Acta Neurochir (Wien) (2000) 0.79

Expression change of interleukin-8 gene in rabbit basilar artery after subarachnoid hemorrhage. Neurosci Bull (2007) 0.78

Inhibition of nitric oxide generation and lipid peroxidation attenuates hemolysate-induced injury to cerebrovascular endothelium. Acta Neurochir (Wien) (1997) 0.78

Sodium nitrite as a therapeutic agent for central nervous system diseases. Surg Neurol (2006) 0.78

Update on evidence for a genetic predisposition to cerebral vasospasm. Neurosurg Focus (2006) 0.78

Platelet-derived growth factor (PDGF-AB) like immune reactivity in serum and in cerebral spinal fluid following experimental subarachnoid haemorrhage in dogs. Acta Neurochir (Wien) (1999) 0.78

Nitric oxide and vasospasm. Acta Neurochir Suppl (2001) 0.77

The role of hemoglobin in the etiology of cerebral vasospasm. An in vivo study of baboons. J Neurosurg (1983) 0.76